Samsung Biologics Co Ltd
- Indústria
- Pharma R&D Outsourcing
- Bolsa
- Coreia
- País / Região
- Korea
- Funcionários
- 5.195
Faixa de valuation composta · conservador 850,000–1,100,000 / justo 1,250,000–1,600,000 / otimista 1,900,000–2,300,000. A 1,430,000, Dentro da faixa de valor intrínseco justo.
Na publicação 1,336,000 (5 de junho de 2026)
Ainda não há análises sobre este ativo no seu idioma.
Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Dados da EODHD, apresentados na moeda de reporte; apenas para referência, não constitui recomendação de investimento.
História
Em breveEsta seção está sendo preenchida — volte em breve.
Posição no setor
Em breveEsta seção está sendo preenchida — volte em breve.